Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

CarParts.com Q4 EPS $(0.11), Inline, Sales $154.52M Beat $151.18M Estimate

CarParts.com (NASDAQ:PRTS) reported quarterly losses of $(0.11) per share which met the analyst consensus estimate. This is a 10 percent decrease over losses of $(0.10) per share from the same period last year. The
byBenzinga Newsdesk
March 7, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

CarParts.com (NASDAQ:PRTS) reported quarterly losses of $(0.11) per share which met the analyst consensus estimate. This is a 10 percent decrease over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $154.52 million which beat the analyst consensus estimate of $151.18 million by 2.21 percent. This is a 11.76 percent increase over sales of $138.26 million the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Canadian CBD-Focused Pharma Co. Gets Green Light To Produce Medical Marijuana In Brazil

By Jelena Martinovic
February 7, 12:05 PM
Canada's MediPharm Labs has received a GMP certification from the Brazilian governing body, ANVISA. The approval allows for the production of active pharmaceutical ingredients (APIs) and end products for the Brazilian medical cannabis market. MediPharm has already received GMP certifications from the US FDA, the European Union, and Australia's TGA, and holds a drug establishment license from Health Canada. The Brazilian medical cannabis market is projected to reach CAD380m (USD282m) by 2025, according to industry forecasts. MediPharm Labs, which already produces two medical cannabis products with full ANVISA authorization for the Brazilian market, is potentially set for further product authorizations through the regulatory body, according to reports.

MEDIF